SCHEMBL23329080

SCHEMBL23329080

OCc1[nH]nnc1-c1ccc(-c2cccnc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MKNK1 Q9BUB5 4/20 0.55
▸ MKNK2 Q9HBH9 4/20 0.55
▸ CYP2A6 P11509 6/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ CYP1A2 P05177 2/20 0.44
▸ CYP11B2 P19099 2/20 0.41
▸ KIF11 P52732 1/20 0.41
▸ GAA P10253 1/20 0.40
▸ FYN P06241 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ FGFR1 P11362 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23329217 0.79 GP6 (0.41) MKNK1ALDH1A1GAAKDM4EMAPT
SCHEMBL18004675 0.77 CYP11B2 (0.55) MKNK1MKNK2CYP2A6ALDH1A1CYP3A4
SCHEMBL29852332 0.75 MKNK1 (0.56) MKNK1MKNK2CYP2A6ALDH1A1CYP3A4
SCHEMBL23294594 0.75 MKNK1 (0.56) MKNK1MKNK2CYP2A6ALDH1A1CYP3A4
SCHEMBL29852180 0.75 MKNK1 (0.56) MKNK1MKNK2CYP2A6ALDH1A1CYP3A4
SCHEMBL23294359 0.75 MKNK1 (0.56) MKNK1MKNK2CYP2A6ALDH1A1CYP3A4
SCHEMBL23329267 0.73 KDM4E (0.41) CYP2A6ALDH1A1CYP1A2KDM4ELMNA
SCHEMBL23328899 0.73 ESR1 (0.45) ALDH1A1CYP1A2CYP11B2HPGDCYP19A1
SCHEMBL6212482 0.72 MKNK1 (1.00) MKNK1MKNK2CYP2A6ALDH1A1CYP3A4
SCHEMBL30462079 0.72 MKNK1 (1.00) MKNK1MKNK2CYP2A6ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11806335-B2 Heterocyclic carboxylate compounds as glycolate oxidase inhibitors Lilac Therapeutics, Inc. (US) 2023-11-07 — — US disclosed
US-20210128532-A1 HETEROCYCLIC CARBOXYLATE COMPOUNDS AS GLYCOLATE OXIDASE INHIBITORS Lilac Therapeutics, Inc. 2021-05-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11806335-B2 Heterocyclic carboxylate compounds as glycolate oxidase inhibitors UGDH, PGD, PNPO MKNK1 3973/4885MKNK2 3939/4885CYP2A6 599/4885
US-20210128532-A1 HETEROCYCLIC CARBOXYLATE COMPOUNDS AS GLYCOLATE OXIDASE INHIBITORS UGDH, PGD, PNPO MKNK1 3973/4885MKNK2 3939/4885CYP2A6 599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback